Radiation therapy of malignant melanoma: experience with high individual treatment doses.

Cancer
H J Habermalz, J J Fischer

Abstract

Reports of the existence of a large shoulder on the radiation survival curve of cultured mouse and human malignant melanoma cells prompted a clinical trial of radiation therapy using high individual-dose-fractionation schedules. Typically, individual doses of larger than or equal to 600 rads were delivered once or twice weekly. The most clear-cut effect was against skin metastases. Twenty-nine of 33 lesions showed partial or complete regression when treated in this manner. None of 11 lesions responded that were treated with individual treatment doses of 200 to 500 rads, although in some cases the total doses were greater than 5000 rads. Some of the possible roles for an effective radiation regimen in the overall management of this complex disease are discussed.

References

Apr 1, 1974·Clinical Radiology·A SealyB Shepstone
Feb 1, 1972·The British Journal of Radiology·S Hornsey
Oct 1, 1971·The British Journal of Radiology·D L Dewey
Feb 15, 1963·Annals of the New York Academy of Sciences·W HELLRIEGEL

❮ Previous
Next ❯

Citations

Nov 1, 1996·Seminars in Surgical Oncology·R K Schmidt-Ullrich, C R Johnson
Apr 1, 1990·Journal of Surgical Oncology·M ChadhaL L Anderson
Jul 30, 1979·World Journal of Surgery·E M HershC M McBride
Nov 25, 2003·Australasian Physical & Engineering Sciences in Medicine·H FukudaM Ichihashi
Mar 1, 2007·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·B S Mehta, Hiten Maniyar
Jan 1, 1980·British Journal of Hospital Medicine·G W Milton
May 1, 1981·International Journal of Radiation Oncology, Biology, Physics·B Fertil, E P Malaise
Jul 1, 1984·International Journal of Radiation Oncology, Biology, Physics·R R Weichselbaum
Mar 1, 1984·Clinical Radiology·M S Khan, W M Ross
Dec 1, 1996·The Surgical Clinics of North America·F B Geara, K K Ang
Dec 1, 1984·Ophthalmology·S PackerP Salanitro
Oct 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S Dische
Feb 1, 1994·Journal of the American Academy of Dermatology·H GoldschmidtD L Breneman
Apr 18, 2002·International Journal of Radiation Oncology, Biology, Physics·Matthew T BalloMerrick I Ross
Oct 24, 2000·Clinical and Experimental Dermatology·R Stadler, D Eich
Oct 6, 1983·The New England Journal of Medicine·L R ProsnitzJ B Weissberg
May 1, 1996·The Australasian Journal of Dermatology·J W de Launey, A R MacKenzie-Wood
Feb 1, 1978·The Australian and New Zealand Journal of Surgery·B Kynaston
Jul 1, 1994·Journal of Veterinary Internal Medicine·K E BatemanS A Kruth
Feb 1, 1979·The Journal of Dermatologic Surgery and Oncology·J S CooperR S Bart
Aug 1, 1982·The British Journal of Radiology·J S AdamJ Kirk
Sep 1, 1991·The British Journal of Radiology·R M Singhal, A Narayana
Dec 1, 1991·The British Journal of Radiology·D Gilligan, N J Slevin
Jul 1, 1980·The British Journal of Radiology·E K Rofstad, T Brustad
Feb 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Atif J KhanBruce G Haffty
Jan 1, 1984·Acta Radiologica. Oncology·I C StridsklevO Klepp
Jan 1, 1986·Acta Radiologica. Oncology·E K Rofstad
Feb 21, 2016·Neuropharmacology·Lumeng J YuSuzie Chen
Nov 1, 1993·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·R Ben-Yosef, D S Kapp
Jun 21, 2015·Expert Review of Neurotherapeutics·Lumeng J YuSuzie Chen
Oct 1, 1983·Ophthalmology·D H CharG F Hilton
Feb 1, 1985·Ophthalmology·E S GragoudasA Koehler
Jul 18, 2012·Dermatologic Clinics·Christopher A Barker, Nancy Y Lee
Feb 1, 1983·International Journal of Radiation Oncology, Biology, Physics·H D ThamesL Milas
Jun 1, 1979·International Journal of Radiation Oncology, Biology, Physics·T H WassermanG VanRaalte

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
P A LoboA M Kanji
International Journal of Radiation Oncology, Biology, Physics
K R TrottA M Kellerer
Cancer Treatment Reviews
A R Harwood, B J Cummings
© 2022 Meta ULC. All rights reserved